Characteristic | After MAP (1:2) 117 | P | |
---|---|---|---|
OIN (39) | IC (78) | ||
Mean age, yr (range) | 63.6 (51.5–76.0) | 64.0 (52.0–74.8) | 0.885a |
Sex ratio (M/F) | 34/5 | 68/10 | match |
Mean BMI, kg/m2 (range) | 21.7 (18.7–24.4) | 22.0 (18.8–25.4) | 0.637a |
ASA class, N (%) | Match | ||
1 | 6 (15.4) | 12 (15.4) | |
2 | 24 (61.5) | 48 (61.5) | |
3 | 9 (23.1) | 18 (23.1) | |
Smoking history, N (%) | 9 (23.1) | 20 (25.6) | 0.762c |
Previous abdominal or pelvic surgery, N (%) | 4 (10.3) | 11 (14.1) | 0.558c |
Comorbidities, N (%) | |||
Cardiovascular disease | 3 (7.7) | 8 (10.3) | 0.911b |
Pulmonary disease | 5 (12.8) | 16 (20.5) | 0.307c |
Hypertension | 9 (23.1) | 28 (35.9) | 0.160c |
Diabetes | 7 (17.9) | 16 (20.5) | 0.742c |
Histological type, N (%) | 0.890b | ||
Pure TCC | 36 (92.3) | 74 (94.9) | |
Other pathology | 3 (7.7) | 4 (5.1) | |
Histological grade, N (%) | 0.651c | ||
Grade 1 and Grade 2 | 9 (23.1) | 15 (19.2) | |
Grade 3 | 28 (71.8) | 58 (74.4) | |
Pathologic T stage, N (%) | 0.476a | ||
Organ-confined: ≤pT2, pN0 | 33 (84.6) | 62 (79.5) | |
Non-organ-confined: pT3-pT4, pN0 | 6 (15.4) | 14 (17.9) | |
Lymph node-positive: pN+ | 0 | 2 (2.6) | |
Highest grade of complication, N (%) | 0.562a | ||
I | 4 (10.3) | 8 (10.3) | |
II | 4 (10.3) | 7 (9.0) | |
III | 3 (7.7) | 3 (3.8) | |
IV | 0 | 0 | |
V | 0 | 0 |